Coronavirus destroys vitamin D: its deficiency was revealed in hospitalized patients

Coronavirus destroys vitamin D in the body

About 80% of hospitalized patients diagnosed with the COVID-19 have severe vitamin D deficiency. The researchers came to that conclusion while studying the features of the coronavirus. Vitamin D is an important hormone for the body that is produced by the kidneys. Its function is to control the concentration of calcium in the blood and affect the immune system. When there is not enough the vitamin in the body, various health problems can arise.

When the vitamin is in abundance, then its beneficial effects on immunity, especially in relation to protection against various infectious diseases. Jose Hernandez, Ph.D. at the University of Cantabria in Spain, believes that he and his colleagues identified an important factor in the impact of the coronavirus on the human body.

In fact, the diagnosis of a patient can be determined by the approach of identifying and treating vitamin D deficiency. A vitamin deficiency can occur in people who find themselves at high risk for the coronavirus: these are elderly people with a number of concomitant and chronic diseases, they can be considered as the main target group for the COVID -19.

In any approach to treating elderly patients with a diagnosis of the COVID-19, a course of vitamin D is required, since in those who are sick, its level in the blood decreases sharply. Prevention of the vitamin, as well as its timely prescription in the first stages of treatment for the coronavirus infection, will have a positive effect on the immune system.

Investigating the condition of patients in one of the hospitals in Spain, the scientists found that out of 216 patients, 80% had a vitamin deficiency. At the same time, the level of vitamin in men was significantly lower than in women. The COVID-19 patients with lower vitamin D levels also had elevated serum levels of inflammatory markers such as ferritin and D-dimer.

Reference “Vitamin D Status in Hospitalized Patients With SARS-Cov-2 Infection” 27 October 2020, Journal of Clinical Endocrinology & Metabolism.